Company Information for KUUR THERAPEUTICS LIMITED
C/O BDO LLP 5 TEMPLE SQUARE, TEMPLE STREET, LIVERPOOL, L2 5RH,
|
Company Registration Number
05620555
Private Limited Company
Liquidation |
Company Name | ||||
---|---|---|---|---|
KUUR THERAPEUTICS LIMITED | ||||
Legal Registered Office | ||||
C/O BDO LLP 5 TEMPLE SQUARE TEMPLE STREET LIVERPOOL L2 5RH Other companies in NW1 | ||||
Previous Names | ||||
|
Company Number | 05620555 | |
---|---|---|
Company ID Number | 05620555 | |
Date formed | 2005-11-11 | |
Country | ||
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Liquidation | |
Lastest accounts | 31/12/2018 | |
Account next due | 25/09/2021 | |
Latest return | 11/11/2015 | |
Return next due | 09/12/2016 | |
Type of accounts | GROUP | |
VAT Number /Sales tax ID |
Last Datalog update: | 2022-08-07 02:08:24 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Officer | Role | Date Appointed |
---|---|---|
ZAFAR QADIR |
||
NIGEL ROBERT BURNS |
||
THOMAS HECHT |
||
IP2IPO SERVICES LIMITED |
||
ANNALISA JENKINS |
||
ALLAN PATRICK MARCHINGTON |
||
GREGG STEPHEN SANDO |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
NIGEL AARON PITCHFORD |
Director | ||
ANDREA PONTI |
Director | ||
MAINA BHAMAN |
Director | ||
JEFF HAMMEL |
Company Secretary | ||
TINA LESLEY CROMBIE |
Company Secretary | ||
SARAH BRITTON HAVENS |
Company Secretary | ||
SWIFT INCORPORATIONS LIMITED |
Nominated Secretary |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
BOWERS MILL FREEHOLD COMPANY LIMITED | Director | 2015-12-04 | CURRENT | 2012-05-21 | Active | |
SWEET SPOT THERAPEUTICS (CONSULTING) LTD | Director | 2015-08-27 | CURRENT | 2015-08-27 | Active | |
BUDCO 3 LIMITED | Director | 2012-04-03 | CURRENT | 2012-04-03 | Dissolved 2015-06-16 | |
BUDCO 4 LIMITED | Director | 2012-04-03 | CURRENT | 2012-04-03 | Dissolved 2015-06-16 | |
BUDCO 5 LIMITED | Director | 2012-04-03 | CURRENT | 2012-04-03 | Dissolved 2015-06-16 | |
BUDCO 2 LIMITED | Director | 2012-04-03 | CURRENT | 2012-04-03 | Dissolved 2015-06-16 | |
SWEETSPOT THERAPEUTICS LTD | Director | 2012-01-30 | CURRENT | 2011-01-17 | Dissolved 2015-10-07 | |
CONCIRRUS LTD | Director | 2018-07-23 | CURRENT | 2011-09-30 | Active | |
ARTIOS PHARMA LIMITED | Director | 2018-06-25 | CURRENT | 2015-12-29 | Active | |
CRYSALIN LIMITED | Director | 2018-06-21 | CURRENT | 2007-04-27 | Liquidation | |
SILICON MICROGRAVITY LIMITED | Director | 2018-06-06 | CURRENT | 2014-09-16 | Active | |
IESO DIGITAL HEALTH LIMITED | Director | 2018-04-26 | CURRENT | 2000-09-01 | Active | |
PERACHEM HOLDINGS PLC | Director | 2018-04-26 | CURRENT | 2005-04-15 | Liquidation | |
NEXEON LIMITED | Director | 2018-04-18 | CURRENT | 2006-02-22 | Active | |
EPSILON-3 BIO LIMITED | Director | 2018-04-16 | CURRENT | 2010-06-18 | Liquidation | |
APCINTEX LIMITED | Director | 2018-04-05 | CURRENT | 2014-06-16 | Active | |
OXFORD BIOTRANS LIMITED | Director | 2018-03-27 | CURRENT | 2013-08-14 | Active | |
OXULAR LIMITED | Director | 2018-03-27 | CURRENT | 2014-11-27 | Active | |
WAVE OPTICS LIMITED | Director | 2018-03-26 | CURRENT | 2012-09-05 | Active | |
TELECTICA LTD | Director | 2018-03-22 | CURRENT | 2012-12-11 | Active | |
TEYA REWARDS LTD. | Director | 2018-03-21 | CURRENT | 2013-05-03 | Active | |
IMPRESSION TECHNOLOGIES LIMITED | Director | 2018-03-13 | CURRENT | 2012-03-30 | Active | |
COVENTRY INTERNATIONAL PRESSING COMPANY LTD | Director | 2018-03-13 | CURRENT | 2015-02-02 | Active | |
PULMOCIDE LIMITED | Director | 2018-03-12 | CURRENT | 2007-03-23 | Active | |
CARDIAN LIMITED | Director | 2018-03-12 | CURRENT | 2016-12-21 | Liquidation | |
AUTIFONY THERAPEUTICS LIMITED | Director | 2018-03-12 | CURRENT | 2011-02-25 | Active | |
INIVATA LIMITED | Director | 2018-03-07 | CURRENT | 2014-07-23 | Active | |
SAM LABS LTD. | Director | 2018-02-28 | CURRENT | 2014-04-23 | Active | |
MISSION THERAPEUTICS LIMITED | Director | 2018-02-15 | CURRENT | 2011-05-11 | Active | |
STORM THERAPEUTICS LIMITED | Director | 2018-02-14 | CURRENT | 2015-04-21 | Active | |
ECONIC TECHNOLOGIES LTD | Director | 2018-02-14 | CURRENT | 2011-06-24 | Active | |
SPIREA LIMITED | Director | 2017-12-14 | CURRENT | 2015-10-09 | Active | |
MOA TECHNOLOGY LIMITED | Director | 2017-10-25 | CURRENT | 2017-08-02 | Active | |
PANCREGENESIS LIMITED | Director | 2017-10-17 | CURRENT | 2017-10-17 | Active - Proposal to Strike off | |
QUANTUM MOTION TECHNOLOGIES LIMITED | Director | 2017-08-11 | CURRENT | 2017-07-14 | Active | |
CHROMOSOL LIMITED | Director | 2017-06-09 | CURRENT | 2017-06-09 | Liquidation | |
EDGETIC LIMITED | Director | 2017-05-15 | CURRENT | 2017-05-15 | Liquidation | |
ALESI SURGICAL LIMITED | Director | 2017-03-02 | CURRENT | 2007-03-01 | Active | |
ART OF XEN LIMITED | Director | 2017-02-22 | CURRENT | 2001-06-15 | Active | |
ACCELERCOMM LTD | Director | 2016-12-21 | CURRENT | 2016-03-04 | Active | |
MICROBIOTICA LIMITED | Director | 2016-12-15 | CURRENT | 2016-07-08 | Active | |
CELLTRON NETWORKS LIMITED | Director | 2016-10-19 | CURRENT | 2016-10-19 | Active - Proposal to Strike off | |
APERIO PHARMA LIMITED | Director | 2016-10-13 | CURRENT | 2016-10-13 | Active - Proposal to Strike off | |
MIXERGY LIMITED | Director | 2016-08-26 | CURRENT | 2014-07-18 | Active | |
UNIPHY LIMITED | Director | 2016-07-11 | CURRENT | 2016-02-12 | Active | |
DYNAMIC VISION SYSTEMS LIMITED | Director | 2016-07-07 | CURRENT | 2014-10-07 | Active - Proposal to Strike off | |
ULTRALEAP HOLDINGS LIMITED | Director | 2016-06-13 | CURRENT | 2016-03-08 | Active | |
DEFENITION LIMITED | Director | 2016-05-11 | CURRENT | 2016-05-11 | Active | |
CERYX MEDICAL LIMITED | Director | 2016-05-03 | CURRENT | 2016-02-12 | Active | |
PULMONIR LIMITED | Director | 2016-03-15 | CURRENT | 2016-02-02 | Active - Proposal to Strike off | |
ASTERION LIMITED | Director | 2016-03-08 | CURRENT | 2000-12-21 | Active | |
FLUID PHARMA LTD | Director | 2016-03-03 | CURRENT | 2016-03-03 | Active | |
ZEETTA NETWORKS LIMITED | Director | 2015-12-22 | CURRENT | 2015-01-20 | Active | |
NAVENIO LIMITED | Director | 2015-12-04 | CURRENT | 2015-10-28 | Active | |
ADJUVANTIX LIMITED | Director | 2015-10-09 | CURRENT | 1999-10-28 | Dissolved 2016-07-12 | |
RELITECT LIMITED | Director | 2015-02-20 | CURRENT | 2014-11-17 | Active - Proposal to Strike off | |
8POWER LIMITED | Director | 2015-01-20 | CURRENT | 2015-01-20 | Active | |
PHASE FOCUS LIMITED | Director | 2014-12-17 | CURRENT | 2006-06-23 | Active | |
ULTRAMATIS LIMITED | Director | 2014-11-19 | CURRENT | 2014-11-19 | Active - Proposal to Strike off | |
DUKOSI LIMITED | Director | 2014-11-19 | CURRENT | 2003-11-27 | Active | |
MAGNOMATICS LIMITED | Director | 2014-11-07 | CURRENT | 2006-07-17 | Active | |
PERPETUUM LIMITED | Director | 2014-10-01 | CURRENT | 2004-06-04 | Active - Proposal to Strike off | |
EIGHT19 LIMITED | Director | 2014-09-22 | CURRENT | 2010-07-22 | Active | |
UMIP PROJECT 001 LIMITED | Director | 2014-07-29 | CURRENT | 2014-07-29 | Dissolved 2016-09-06 | |
UMIP PROJECT 003 LIMITED | Director | 2014-07-29 | CURRENT | 2014-07-29 | Active - Proposal to Strike off | |
BOXARR LIMITED | Director | 2014-07-24 | CURRENT | 2003-08-20 | Active | |
EXTRAJECT TECHNOLOGIES LTD | Director | 2014-07-23 | CURRENT | 2013-01-21 | Active | |
MEDELLA THERAPEUTICS LIMITED | Director | 2014-07-23 | CURRENT | 2007-02-08 | Active - Proposal to Strike off | |
PH THERAPEUTICS LIMITED | Director | 2014-07-23 | CURRENT | 2013-03-06 | Active | |
UMIP PROJECT 002 LIMITED | Director | 2014-07-03 | CURRENT | 2014-07-03 | Dissolved 2017-10-17 | |
CREAVO MEDICAL TECHNOLOGIES LIMITED | Director | 2014-04-01 | CURRENT | 2014-01-31 | Liquidation | |
OXSYBIO LIMITED | Director | 2014-03-03 | CURRENT | 2014-03-03 | Liquidation | |
IONIX ADVANCED TECHNOLOGIES LTD | Director | 2013-12-23 | CURRENT | 2011-08-04 | Active | |
SAW DX LIMITED | Director | 2013-08-12 | CURRENT | 2013-03-11 | Active - Proposal to Strike off | |
SPINETIC ENERGY LIMITED | Director | 2013-05-24 | CURRENT | 2012-05-28 | Liquidation | |
UBIQUIGENT LTD | Director | 2013-04-04 | CURRENT | 2009-07-10 | Active | |
AZURI TECHNOLOGIES LTD | Director | 2012-12-21 | CURRENT | 2012-07-10 | Active | |
PHOTOPHARMICA LIMITED | Director | 2012-12-21 | CURRENT | 2012-12-03 | Dissolved 2018-06-12 | |
OXEHEALTH LIMITED | Director | 2012-09-13 | CURRENT | 2012-07-31 | Active | |
OXFORD DRUG DESIGN LIMITED | Director | 2012-07-10 | CURRENT | 2001-10-17 | Active | |
CRYPTOGRAPHIQ LIMITED | Director | 2012-06-25 | CURRENT | 2012-06-25 | Active - Proposal to Strike off | |
SEREN PHOTONICS LIMITED | Director | 2012-03-06 | CURRENT | 2009-11-04 | Active - Proposal to Strike off | |
PHOTOPHARMICA LEEDS LIMITED | Director | 2011-09-22 | CURRENT | 2001-03-06 | Dissolved 2015-08-18 | |
FIRST LIGHT FUSION LIMITED | Director | 2011-06-30 | CURRENT | 2011-03-08 | Active | |
UNION LIFE SCIENCES LIMITED | Director | 2011-04-14 | CURRENT | 2006-02-16 | Active - Proposal to Strike off | |
ARKIVUM LIMITED | Director | 2011-03-24 | CURRENT | 2011-02-15 | Active | |
ANACAIL LIMITED | Director | 2011-02-23 | CURRENT | 2010-11-03 | Liquidation | |
CH4E LIMITED | Director | 2011-02-18 | CURRENT | 2009-01-07 | Dissolved 2016-10-27 | |
MBS DIRECTOR LIMITED | Director | 2009-09-02 | CURRENT | 2007-05-23 | Active - Proposal to Strike off | |
MBS SECRETARIAL LIMITED | Director | 2009-09-02 | CURRENT | 2007-05-23 | Active - Proposal to Strike off | |
MODERN BIOSCIENCES NOMINEES LIMITED | Director | 2009-08-04 | CURRENT | 2007-06-14 | Active | |
MODERN BIOSCIENCES LIMITED | Director | 2009-06-02 | CURRENT | 2005-04-05 | Active | |
C-CAPTURE LIMITED | Director | 2009-05-21 | CURRENT | 2009-05-21 | Active | |
AMAETHON LIMITED | Director | 2009-04-17 | CURRENT | 2003-07-30 | Liquidation | |
AZELLON LTD | Director | 2009-01-05 | CURRENT | 2007-12-07 | Active - Proposal to Strike off | |
POLAR OLED LTD | Director | 2008-11-26 | CURRENT | 2008-11-26 | Active - Proposal to Strike off | |
ENCOS LIMITED | Director | 2008-11-13 | CURRENT | 2007-04-23 | Dissolved 2017-04-11 | |
IKSUDA THERAPEUTICS LIMITED | Director | 2008-09-04 | CURRENT | 2007-11-21 | Active | |
DISPERSIA LIMITED | Director | 2008-08-01 | CURRENT | 2006-01-31 | Dissolved 2014-05-27 | |
DYECAT LIMITED | Director | 2008-08-01 | CURRENT | 2005-10-03 | Dissolved 2014-05-06 | |
CHAMELIC LIMITED | Director | 2008-08-01 | CURRENT | 2006-02-16 | Dissolved 2015-08-11 | |
STRUCTURE VISION LIMITED | Director | 2008-08-01 | CURRENT | 2003-03-20 | Active | |
SUSTAINABLE RESOURCE SOLUTIONS LIMITED | Director | 2008-07-25 | CURRENT | 2007-04-30 | Dissolved 2015-07-14 | |
RIO AI LIMITED | Director | 2008-04-09 | CURRENT | 1997-10-01 | Active | |
EMDOT LIMITED | Director | 2007-08-02 | CURRENT | 2007-08-02 | Active | |
MDL 2016 LIMITED | Director | 2007-02-22 | CURRENT | 2006-02-10 | Dissolved 2018-03-06 | |
SURREY NANOSYSTEMS LIMITED | Director | 2006-11-28 | CURRENT | 1999-06-02 | Active | |
PHARMINOX LIMITED | Director | 2006-09-15 | CURRENT | 2001-12-28 | Active - Proposal to Strike off | |
CAPSANT NEUROTECHNOLOGIES LIMITED | Director | 2006-06-28 | CURRENT | 2002-06-21 | Liquidation | |
SILENCE THERAPEUTICS PLC | Director | 2017-10-16 | CURRENT | 1994-11-18 | Active |
Date | Document Type | Document Description |
---|---|---|
Voluntary liquidation Statement of receipts and payments to 2023-05-24 | ||
TM02 | Termination of appointment of Broughton Secretaries Limited on 2022-05-30 | |
REGISTERED OFFICE CHANGED ON 06/06/22 FROM 54 Portland Place London W1B 1DY England | ||
AD01 | REGISTERED OFFICE CHANGED ON 06/06/22 FROM 54 Portland Place London W1B 1DY England | |
LIQ01 | Voluntary liquidation declaration of solvency | |
600 | Appointment of a voluntary liquidator | |
LRESSP | Resolutions passed:
| |
Compulsory strike-off action has been suspended | ||
DISS16(SOAS) | Compulsory strike-off action has been suspended | |
GAZ1 | FIRST GAZETTE notice for compulsory strike-off | |
CS01 | CONFIRMATION STATEMENT MADE ON 23/09/21, WITH NO UPDATES | |
AA01 | Previous accounting period shortened from 30/06/20 TO 29/06/20 | |
RP04AP01 | Second filing of director appointment of Mr Daniel Lang | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR KEVIN SEAN BOYLE SR | |
AP01 | DIRECTOR APPOINTED MR DANIEL LANG | |
AA01 | Previous accounting period extended from 31/12/19 TO 30/06/20 | |
MR04 | STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 056205550001 | |
CS01 | CONFIRMATION STATEMENT MADE ON 23/09/20, WITH UPDATES | |
RP04CS01 | ||
RES12 | Resolution of varying share rights or name | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
SH08 | Change of share class name or designation | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR JULIA PAIGE GREGORY | |
CS01 | CONFIRMATION STATEMENT MADE ON 02/06/20, WITH UPDATES | |
SH08 | Change of share class name or designation | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
SH01 | 28/02/20 STATEMENT OF CAPITAL GBP 4000533.5 | |
MR01 | REGISTRATION OF A CHARGE / CHARGE CODE 056205550001 | |
CH01 | Director's details changed for Dr Thomas Hecht on 2020-03-06 | |
AP04 | Appointment of Broughton Secretaries Limited as company secretary on 2020-03-06 | |
AD01 | REGISTERED OFFICE CHANGED ON 06/03/20 FROM 1 Canal Side Studios 8-14 st Pancras Way London NW1 0QG | |
PSC08 | Notification of a person with significant control statement | |
PSC08 | Notification of a person with significant control statement | |
PSC07 | CESSATION OF INVESCO LTD AS A PERSON OF SIGNIFICANT CONTROL | |
PSC07 | CESSATION OF INVESCO LTD AS A PERSON OF SIGNIFICANT CONTROL | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR CHRISTOPHER JOHN NOWERS | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR CHRISTOPHER JOHN NOWERS | |
AP01 | DIRECTOR APPOINTED MR KEVIN SEAN BOYLE SR | |
AP01 | DIRECTOR APPOINTED MR KEVIN SEAN BOYLE SR | |
RES15 | CHANGE OF COMPANY NAME 13/02/20 | |
RES15 | CHANGE OF COMPANY NAME 13/02/20 | |
CS01 | CONFIRMATION STATEMENT MADE ON 11/11/19, WITH UPDATES | |
CS01 | CONFIRMATION STATEMENT MADE ON 11/11/19, WITH UPDATES | |
TM02 | Termination of appointment of Mirza Zafar Iskander Qadir on 2019-10-31 | |
TM02 | Termination of appointment of Mirza Zafar Iskander Qadir on 2019-10-31 | |
RES10 | Resolutions passed:
| |
RES10 | Resolutions passed:
| |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/18 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR NIGEL ROBERT BURNS | |
CH01 | Director's details changed for Mr Allan Patrick Marchington on 2019-01-24 | |
CS01 | CONFIRMATION STATEMENT MADE ON 11/11/18, WITH UPDATES | |
AP01 | DIRECTOR APPOINTED MR CHRISTOPHER JOHN NOWERS | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR GREGG STEPHEN SANDO | |
CH03 | SECRETARY'S DETAILS CHNAGED FOR MR ZAFAR QADIR on 2016-12-08 | |
AP01 | DIRECTOR APPOINTED MS JULIA PAIGE GREGORY | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/17 | |
AP02 | Appointment of Ip2Ipo Services Limited as director on 2018-03-28 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR NIGEL PITCHFORD | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ANDREA PONTI | |
AP01 | DIRECTOR APPOINTED MR NIGEL AARON PITCHFORD | |
AP01 | DIRECTOR APPOINTED MR NIGEL AARON PITCHFORD | |
AP01 | DIRECTOR APPOINTED MRS ANNALISA JENKINS | |
PSC07 | CESSATION OF IMPERIAL INNOVATIONS BUSINESSES LLP AS A PERSON OF SIGNIFICANT CONTROL | |
LATEST SOC | 11/12/17 STATEMENT OF CAPITAL;GBP 2022511.5 | |
SH01 | 30/11/17 STATEMENT OF CAPITAL GBP 2022511.5 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR MAINA BHAMAN | |
CS01 | CONFIRMATION STATEMENT MADE ON 11/11/17, WITH UPDATES | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/16 | |
SH01 | 04/07/16 STATEMENT OF CAPITAL GBP 1391540.80 | |
SH01 | 27/05/16 STATEMENT OF CAPITAL GBP 1318484.80 | |
SH01 | 17/11/16 STATEMENT OF CAPITAL GBP 1393140.8 | |
LATEST SOC | 13/04/17 STATEMENT OF CAPITAL;GBP 1672861.1 | |
RP04SH01 | Second filing of capital allotment of shares GBP1,672,861.1 | |
ANNOTATION | Clarification | |
SH10 | Particulars of variation of rights attached to shares | |
RES11 | DISAPPLICATION OF PRE-EMPTION RIGHTS | |
RES01 | ADOPT ARTICLES 10/03/2017 | |
SH01 | 15/03/17 STATEMENT OF CAPITAL GBP 29363570.8 | |
AP01 | DIRECTOR APPOINTED MR ALLAN PATRICK MARCHINGTON | |
AP03 | SECRETARY APPOINTED MR ZAFAR QADIR | |
LATEST SOC | 25/11/16 STATEMENT OF CAPITAL;GBP 1391540.8 | |
CS01 | CONFIRMATION STATEMENT MADE ON 11/11/16, WITH UPDATES | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR JOHN SMITHER | |
Annotation | ||
TM02 | APPOINTMENT TERMINATED, SECRETARY JEFF HAMMEL | |
AP01 | DIRECTOR APPOINTED MR JOHN WILLIAM SMITHER | |
Annotation | ||
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/15 | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
SH10 | NOTICE OF PARTICULARS OF VARIATION OF RIGHTS ATTACHED TO SHARES | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
SH10 | NOTICE OF PARTICULARS OF VARIATION OF RIGHTS ATTACHED TO SHARES | |
LATEST SOC | 09/06/16 STATEMENT OF CAPITAL;GBP 1273346 | |
SH01 | 12/05/16 STATEMENT OF CAPITAL GBP 1273346 | |
RES11 | DISAPPLICATION OF PRE-EMPTION RIGHTS | |
RES01 | ADOPT ARTICLES 11/05/2016 | |
RES01 | ADOPT ARTICLES 11/05/2016 | |
RES13 | CONSENT TO PASSING OF ALL RESOLUTIONS 11/05/2016 | |
RES13 | CONSENT TO PASSING OF ALL RESOLUTIONS 11/05/2016 | |
RES01 | ADOPT ARTICLES 11/05/2016 | |
LATEST SOC | 24/11/15 STATEMENT OF CAPITAL;GBP 923695.7 | |
AR01 | 11/11/15 FULL LIST | |
AUD | AUDITOR'S RESIGNATION | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/14 | |
AR01 | 11/11/14 FULL LIST | |
RES13 | OTHER COMPANY BUSINESS 24/11/2014 | |
RES01 | ADOPT ARTICLES 24/11/2014 | |
SH10 | NOTICE OF PARTICULARS OF VARIATION OF RIGHTS ATTACHED TO SHARES | |
SH08 | NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES | |
LATEST SOC | 27/11/14 STATEMENT OF CAPITAL;GBP 832573.9 | |
SH01 | 24/11/14 STATEMENT OF CAPITAL GBP 832573.9 | |
AP01 | DIRECTOR APPOINTED MR ANDREA PONTI | |
SH01 | 22/05/14 STATEMENT OF CAPITAL GBP 482923.5 | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/13 | |
AP03 | SECRETARY APPOINTED MR JEFF HAMMEL | |
TM02 | APPOINTMENT TERMINATED, SECRETARY TINA CROMBIE | |
AR01 | 11/11/13 FULL LIST | |
CH03 | SECRETARY'S CHANGE OF PARTICULARS / MRS TINA LESLEY CROMBIE / 19/09/2013 | |
SH01 | 19/07/13 STATEMENT OF CAPITAL GBP 482923.5 | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/12 | |
AD01 | REGISTERED OFFICE CHANGED ON 17/01/2013 FROM 27 FITZROY SQUARE LONDON W1T 6ES UNITED KINGDOM | |
AR01 | 11/11/12 FULL LIST | |
AD02 | SAIL ADDRESS CHANGED FROM: C/O CELL MEDICA 27 FITZROY SQUARE LONDON W1T 6ES UNITED KINGDOM | |
AD01 | REGISTERED OFFICE CHANGED ON 06/12/2012 FROM 1 CANAL SIDE STUDIOS 8 - 14 ST PANCRAS WAY LONDON NW1 0QG UNITED KINGDOM | |
AD01 | REGISTERED OFFICE CHANGED ON 05/12/2012 FROM 27 FITZROY SQUARE LONDON W1T 6ES UNITED KINGDOM | |
AA | 31/12/11 TOTAL EXEMPTION SMALL | |
RES11 | DISAPPLICATION OF PRE-EMPTION RIGHTS | |
RES01 | ADOPT ARTICLES 10/07/2012 | |
AR01 | 11/11/11 FULL LIST | |
AA | 31/12/10 TOTAL EXEMPTION SMALL | |
SH01 | 07/03/11 STATEMENT OF CAPITAL GBP 205296.1 | |
AR01 | 11/11/10 FULL LIST | |
AP01 | DIRECTOR APPOINTED DR THOMAS HECHT | |
AA | 31/12/09 TOTAL EXEMPTION SMALL | |
SH01 | 30/06/10 STATEMENT OF CAPITAL GBP 163046.1 | |
88(2) | CAPITALS NOT ROLLED UP | |
AD01 | REGISTERED OFFICE CHANGED ON 10/12/2009 FROM 52 NORLAND SQUARE LONDON W11 4PZ | |
TM02 | APPOINTMENT TERMINATED, SECRETARY SARAH HAVENS | |
SH01 | 05/12/09 STATEMENT OF CAPITAL GBP 132796.1 | |
AR01 | 11/11/09 FULL LIST | |
AD02 | SAIL ADDRESS CREATED | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / GREGG SANDO / 26/11/2009 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / DOCTOR NIGEL ROBERT BURNS / 26/11/2009 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MAINA BHAMAN / 26/11/2009 | |
AP03 | SECRETARY APPOINTED MRS TINA LESLEY CROMBIE | |
AA | 31/12/08 TOTAL EXEMPTION SMALL | |
123 | NC INC ALREADY ADJUSTED 28/07/09 | |
RES12 | VARYING SHARE RIGHTS AND NAMES | |
RES04 | GBP NC 225893.1/346393.1 20/07/2009 | |
88(2) | AD 28/07/09 GBP SI 300000@0.1=30000 GBP IC 102796.1/132796.1 | |
AAMD | AMENDED EXEMPTION FULL ACCOUNTS MADE UP TO 31/12/07 | |
363a | RETURN MADE UP TO 11/11/08; FULL LIST OF MEMBERS | |
123 | NC INC ALREADY ADJUSTED 21/05/08 | |
RES01 | ADOPT ARTICLES 21/05/2008 | |
RES04 | GBP NC 186742.4/225893.10 21/05/2008 | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
88(2) | AD 04/09/08 GBP SI 210527@0.1=21052.7 GBP IC 102795.7/123848.4 | |
123 | NC INC ALREADY ADJUSTED 15/12/06 | |
AA | 31/12/07 TOTAL EXEMPTION FULL | |
88(2) | AD 31/07/08 GBP SI 210527@0.1=21052.7 GBP IC 81743/102795.7 | |
RES01 | ADOPT ARTICLES 15/12/2006 | |
RES04 | GBP NC 25000/18674240 15/12/2006 | |
88(2) | CAPITALS NOT ROLLED UP | |
288a | DIRECTOR APPOINTED MR NIGEL ROBERT BURNS | |
363a | RETURN MADE UP TO 11/11/07; FULL LIST OF MEMBERS | |
225 | ACC. REF. DATE EXTENDED FROM 30/11/07 TO 31/12/07 | |
AA | TOTAL EXEMPTION FULL ACCOUNTS MADE UP TO 30/11/06 | |
288a | NEW DIRECTOR APPOINTED | |
288a | NEW DIRECTOR APPOINTED | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
RES01 | ALTERATION TO MEMORANDUM AND ARTICLES | |
363(288) | SECRETARY'S PARTICULARS CHANGED | |
363s | RETURN MADE UP TO 11/11/06; FULL LIST OF MEMBERS | |
RES01 | ALTERATION TO MEMORANDUM AND ARTICLES | |
RES04 | NC INC ALREADY ADJUSTED 31/07/06 | |
123 | £ NC 1000/25000 31/07/06 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
122 | S-DIV 31/07/06 | |
RES13 | SUB DIV 31/07/06 | |
CERTNM | COMPANY NAME CHANGED IMMUNOCODE LIMITED CERTIFICATE ISSUED ON 18/11/05 | |
288b | SECRETARY RESIGNED | |
NEWINC | INCORPORATION DOCUMENTS CERTIFICATE OF INCORPORATION STATEMENT OF DIRECTORS & REGISTERED OFFICE DECLARATION OF COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
Appointmen | 2022-06-01 |
Resolution | 2022-06-01 |
Notices to | 2022-06-01 |
Total # Mortgages/Charges | 1 |
---|---|
Mortgages/Charges outstanding | 0 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 1 |
|
|
|
|
|
These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on KUUR THERAPEUTICS LIMITED
The top companies supplying to UK government with the same SIC code (21200 - Manufacture of pharmaceutical preparations) as KUUR THERAPEUTICS LIMITED are:
Origin | Destination | Date | Import Code | Imported Goods classification description |
---|---|---|---|---|
39269097 | Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s. | |||
39269097 | Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s. | |||
35029090 | Albuminates and other albumin derivatives | |||
39269097 | Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s. |
For goods imported into the United Kingdom, only imports originating from outside the EU are shown
Initiating party | Event Type | Appointmen | |
---|---|---|---|
Defending party | KUUR THERAPEUTICS LIMITED | Event Date | 2022-06-01 |
Company Number: 05620555 Name of Company: KUUR THERAPEUTICS LIMITED Previous Name of Company: Cell Medica Limited, Immunocode Limited Nature of Business: Manufacture of pharmaceutical preparations Res… | |||
Initiating party | Event Type | Resolution | |
Defending party | KUUR THERAPEUTICS LIMITED | Event Date | 2022-06-01 |
Initiating party | Event Type | Notices to | |
Defending party | KUUR THERAPEUTICS LIMITED | Event Date | 2022-06-01 |
Category | Award/Grant | |
---|---|---|
Phase I/II study investigating safety and efficacy of adenovirus-specific T-cells given to high-risk paediatric patients post-HSCT to treat reactivation of ADV : Collaborative Research and Development | 2012-02-01 | £ 334,069 |
Adenovirus-specific paediaatric immune reconstitution (ASPIRE) : Fast Track | 2010-09-01 | £ 76,239 |
Regenerative medicine value systems: navigating the uncertainties : Collaborative Research and Development | 2010-04-01 | £ 149,156 |
Advanced manufacturing process for the production of individualised cell therapies : Collaborative Research and Development | 2009-09-01 | £ 444,966 |
How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |